IDR 400.0
(-1.48%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 133.25 Billion IDR | 28.43% |
2022 | 103.76 Billion IDR | -45.61% |
2021 | 190.78 Billion IDR | 846.66% |
2020 | 20.15 Billion IDR | 80.6% |
2019 | 11.15 Billion IDR | -60.87% |
2018 | 28.51 Billion IDR | 16.39% |
2017 | 24.5 Billion IDR | 5119.06% |
2016 | -488.18 Million IDR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 135.13 Billion IDR | 1.41% |
2024 Q2 | 168.66 Billion IDR | 24.81% |
2024 Q3 | 305.27 Billion IDR | 81.0% |
2023 Q3 | 116.93 Billion IDR | 29.86% |
2023 Q2 | 90.04 Billion IDR | 9.56% |
2023 FY | 133.25 Billion IDR | 28.43% |
2023 Q1 | 82.19 Billion IDR | -20.79% |
2023 Q4 | 133.25 Billion IDR | 13.96% |
2022 Q2 | 175.83 Billion IDR | 67.97% |
2022 Q4 | 103.76 Billion IDR | -30.02% |
2022 Q3 | 148.27 Billion IDR | -15.67% |
2022 Q1 | 104.67 Billion IDR | -45.13% |
2022 FY | 103.76 Billion IDR | -45.61% |
2021 Q1 | 363.15 Billion IDR | 1701.96% |
2021 FY | 190.78 Billion IDR | 846.66% |
2021 Q4 | 190.78 Billion IDR | -14.23% |
2021 Q3 | 222.43 Billion IDR | -49.9% |
2021 Q2 | 443.95 Billion IDR | 22.25% |
2020 FY | 20.15 Billion IDR | 80.6% |
2020 Q4 | 20.15 Billion IDR | 117.96% |
2020 Q3 | 9.24 Billion IDR | -75.15% |
2020 Q2 | 37.21 Billion IDR | 25.56% |
2020 Q1 | 29.63 Billion IDR | 165.57% |
2019 Q4 | 11.15 Billion IDR | 0.0% |
2019 Q1 | 11.34 Billion IDR | 0.0% |
2019 FY | 11.15 Billion IDR | -60.87% |
2018 FY | 28.51 Billion IDR | 16.39% |
2018 Q1 | - IDR | 0.0% |
2017 FY | 24.5 Billion IDR | 5119.06% |
2016 FY | -488.18 Million IDR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
PT Enseval Putera Megatrading Tbk. | 3843.44 Billion IDR | 96.533% |
PT Kimia Farma (Persero) Tbk | 2504.06 Billion IDR | 94.678% |
PT Millennium Pharmacon International Tbk | 535.87 Billion IDR | 75.132% |
PT Soho Global Health Tbk | 1390.85 Billion IDR | 90.419% |